File Download
  Patent History
  • Application
    US 12/255092 2008-10-21
  • Publication
    US 20090325160 2009-12-31
  • Granted
    US 8076077 2011-12-13
Supplementary

granted patent: Compositions And Methods For Prognosis And Therapy Of Liver Cancer

TitleCompositions And Methods For Prognosis And Therapy Of Liver Cancer
Granted PatentUS 8076077
Granted Date2011-12-13
Priority Date2008-10-21 US 12/255092
2004-08-12 US 11/917195
2003-08-13 US 10/494981P
2003-09-04 US 10/500844P
Inventors
Issue Date2011
Citation
US Patent 8076077. Washington, DC: US Patent and Trademark Office (USPTO), 2011 How to Cite?
AbstractThis Invention Provides A Composition Comprising The Following Polynucleotide Probes: Il7r (Aa485865) (Seq Id No:7), Ndrgi (Aa486403) (Seq Id No:8), Est1 (H50345) (Seq Id No:9), Trpc1 (Aa017132) (Seq Id No:10), Gfra1 (Aa512935) (Seq Id No:11), Est2 (Aa454543) (Seq Id No:12), Cldn10 (R54559) (Seq Id No:13), Dnali1 (R93087) (Seq Id No:14), Rbp5 (Aa453198) (Seq Id No:15), Est3 (Aa621761) (Seq Id No:16), Est4 (N63706) (Seq Id No:17), Pcolce (Aa670200) (Seq Id No:18), Tdo2 (T72398) (Seq Id No:19), Est5 (T47454) (Seq Id No:20), Hist1h2bd (N33927) (Seq Id No:21), Pxmp2 (N70714) (Seq Id No:22), Acas2 (Aa455146) (Seq Id No:23), Anapc7 (T68445) (Seq Id No:24), Est6 (Aa576580) (Seq Id No:25), Rbp5 (N92148) (Seq Id No:26), Anxai (H63077) (Seq Id No:27), Ckb (Aa894557) (Seq Id No:28), Itgbl1 (N52533) (Seq Id No:29), Kpna2 (Aa676460) (Seq Id No:30), Est7 (W90740) (Seq Id No:; 31) And Meg3 (W85841) (Seq Id No:32). This Invention Further Provides Methods For Determining The Likelihood Of Recurrence Of Hepatocellular Carcinoma (Hcc) In A Subject Afflicted With Hcc, For Determining The Likelihood Of Death Of A Subject Afflicted With Hcc Or For Determining Whether To Administer Adjuvant Therapy.
Persistent Identifierhttp://hdl.handle.net/10722/173826
References

 

DC FieldValueLanguage
dc.date.accessioned2012-11-02T06:19:27Z-
dc.date.available2012-11-02T06:19:27Z-
dc.date.issued2011-
dc.identifier.citationUS Patent 8076077. Washington, DC: US Patent and Trademark Office (USPTO), 2011en_HK
dc.identifier.urihttp://hdl.handle.net/10722/173826-
dc.description.abstractThis Invention Provides A Composition Comprising The Following Polynucleotide Probes: Il7r (Aa485865) (Seq Id No:7), Ndrgi (Aa486403) (Seq Id No:8), Est1 (H50345) (Seq Id No:9), Trpc1 (Aa017132) (Seq Id No:10), Gfra1 (Aa512935) (Seq Id No:11), Est2 (Aa454543) (Seq Id No:12), Cldn10 (R54559) (Seq Id No:13), Dnali1 (R93087) (Seq Id No:14), Rbp5 (Aa453198) (Seq Id No:15), Est3 (Aa621761) (Seq Id No:16), Est4 (N63706) (Seq Id No:17), Pcolce (Aa670200) (Seq Id No:18), Tdo2 (T72398) (Seq Id No:19), Est5 (T47454) (Seq Id No:20), Hist1h2bd (N33927) (Seq Id No:21), Pxmp2 (N70714) (Seq Id No:22), Acas2 (Aa455146) (Seq Id No:23), Anapc7 (T68445) (Seq Id No:24), Est6 (Aa576580) (Seq Id No:25), Rbp5 (N92148) (Seq Id No:26), Anxai (H63077) (Seq Id No:27), Ckb (Aa894557) (Seq Id No:28), Itgbl1 (N52533) (Seq Id No:29), Kpna2 (Aa676460) (Seq Id No:30), Est7 (W90740) (Seq Id No:; 31) And Meg3 (W85841) (Seq Id No:32). This Invention Further Provides Methods For Determining The Likelihood Of Recurrence Of Hepatocellular Carcinoma (Hcc) In A Subject Afflicted With Hcc, For Determining The Likelihood Of Death Of A Subject Afflicted With Hcc Or For Determining Whether To Administer Adjuvant Therapy.en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documentsen_US
dc.titleCompositions And Methods For Prognosis And Therapy Of Liver Canceren_HK
dc.typePatenten_US
dc.identifier.emailCheung, ST=stcheung@hkucc.hku.hk-
dc.identifier.emailFan, ST=stfan@hku.hk-
dc.identifier.authorityCheung, ST:rp00457-
dc.identifier.authorityFan, ST:rp00355-
dc.description.naturepublished_or_final_versionen_US
dc.contributor.inventorCheung, ST-
dc.contributor.inventorFan, ST-
patents.identifier.applicationUS 12/255092en_HK
patents.identifier.grantedUS 8076077en_HK
patents.description.assigneeVersitech Ltd [Cn]en_HK
patents.description.countryUnited States of Americaen_HK
patents.date.publication2009-12-31en_HK
patents.date.granted2011-12-13en_HK
dc.relation.referencesUS 2003165854 (A1) 2003-09-04en_HK
patents.identifier.hkutechidSurg-2003-00126-1en_HK
patents.date.application2008-10-21en_HK
patents.date.priority2008-10-21 US 12/255092en_HK
patents.date.priority2004-08-12 US 11/917195en_HK
patents.date.priority2003-08-13 US 10/494981Pen_HK
patents.date.priority2003-09-04 US 10/500844Pen_HK
patents.description.ccUSen_HK
patents.identifier.publicationUS 20090325160en_HK
patents.relation.familyCN 1867671 (A) 2006-11-22en_HK
patents.relation.familyCN 100549172 (C) 2009-10-14en_HK
patents.relation.familyHK 1098783 (A1) 2010-07-02en_HK
patents.relation.familyUS 2009325160 (A1) 2009-12-31en_HK
patents.relation.familyUS 8076077 (B2) 2011-12-13en_HK
patents.relation.familyUS 2005089895 (A1) 2005-04-28en_HK
patents.relation.familyWO 2005017150 (A1) 2005-02-24en_HK
patents.description.kindB2en_HK
patents.typePatent_granteden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats